PIROXICAM

PIROXICAM was reported 6401 times

PIROXICAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 97 0.4236
1 C-REACTIVE PROTEIN 225 0.2427
2 SWOLLEN JOINT COUNT 60 0.2400
3 DEEP VEIN THROMBOSIS POSTOPERATIVE 456 0.2277
4 ADRENOLEUKODYSTROPHY 7 0.2121
5 BENIGN ABDOMINAL NEOPLASM 10 0.2083
6 LUPUS VULGARIS 248 0.1968
7 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 103 0.1542
8 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 16 0.1524
9 X-RAY ABNORMAL 258 0.1441
10 SWOLLEN JOINT COUNT INCREASED 457 0.1432
11 TENDER JOINT COUNT 12 0.1429
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 263 0.1268
13 CHEST EXPANSION DECREASED 11 0.1183
14 RHEUMATIC FEVER 518 0.1161
15 DISLOCATION OF VERTEBRA 230 0.1007
16 PORPHYRIA ACUTE 140 0.0976
17 BLOOD IRON ABNORMAL 94 0.0962
18 RETINITIS 155 0.0896
19 RHEUMATOID FACTOR POSITIVE 500 0.0865
20 FACET JOINT SYNDROME 266 0.0816
21 C-REACTIVE PROTEIN ABNORMAL 515 0.0802
22 HYPOCHOLESTEROLAEMIA 28 0.0793
23 DUODENAL ULCER PERFORATION 565 0.0759
24 GASTROINTESTINAL DYSPLASIA 9 0.0744
25 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 526 0.0733
26 HLA MARKER STUDY POSITIVE 12 0.0732
27 ACQUIRED PORPHYRIA 5 0.0704
28 PERIPHERAL VENOUS DISEASE 272 0.0665
29 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 387 0.0595
30 BLOOD IMMUNOGLOBULIN M INCREASED 33 0.0543
31 MUSCLE INJURY 449 0.0541
32 DRUG TOLERANCE DECREASED 150 0.0534
33 VENTRICULAR ENLARGEMENT 9 0.0511
34 SMALL INTESTINE ADENOCARCINOMA 9 0.0503
35 GAMMOPATHY 9 0.0497
36 HELICOBACTER INFECTION 506 0.0492
37 SCIATICA 784 0.0491
38 SECONDARY HYPOGONADISM 16 0.0485
39 LARYNGEAL DISORDER 35 0.0485
40 BLOOD IMMUNOGLOBULIN A DECREASED 31 0.0476
41 FOLLICULITIS 488 0.0465
42 BONE EROSION 157 0.0444
43 AUTOIMMUNE DISORDER 431 0.0442
44 INTESTINAL DIAPHRAGM DISEASE 12 0.0430
45 LIP DRY 388 0.0427
46 BREAST CANCER STAGE III 273 0.0421
47 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 23 0.0410
48 PEMPHIGUS 507 0.0405
49 RED BLOOD CELL SEDIMENTATION RATE 11 0.0394
50 HAND DEFORMITY 512 0.0390
51 PERSISTENT DEPRESSIVE DISORDER 15 0.0371
52 RECTAL NEOPLASM 9 0.0344
53 BURSITIS 398 0.0328
54 LIVE BIRTH 271 0.0324
55 SERONEGATIVE ARTHRITIS 36 0.0314
56 TRI-IODOTHYRONINE FREE DECREASED 8 0.0314
57 NEUROSIS 14 0.0310
58 PALMOPLANTAR PUSTULOSIS 16 0.0302
59 RHEUMATIC DISORDER 58 0.0300
60 PERICARDITIS 500 0.0297
61 SYNOVITIS 531 0.0294
62 GRIP STRENGTH DECREASED 258 0.0293
63 WOUND INFECTION 319 0.0291
64 JOINT RANGE OF MOTION DECREASED 378 0.0282
65 MATERNAL EXPOSURE TIMING UNSPECIFIED 104 0.0277
66 BLOOD IMMUNOGLOBULIN G INCREASED 33 0.0271
67 ENTHESOPATHY 40 0.0256
68 INFLAMMATORY PAIN 17 0.0250
69 SINONASAL OBSTRUCTION 10 0.0249
70 GASTROINTESTINAL TRACT ADENOMA 9 0.0247
71 LOWER LIMB FRACTURE 474 0.0246
72 SYNOVIAL DISORDER 11 0.0242
73 OVERLAP SYNDROME 16 0.0229
74 GLOSSODYNIA 500 0.0223
75 RED BLOOD CELL SEDIMENTATION RATE INCREASED 243 0.0219
76 SPHINCTER OF ODDI DYSFUNCTION 9 0.0218
77 THERAPEUTIC PRODUCT CROSS-REACTIVITY 19 0.0213
78 FIBROMYALGIA 517 0.0212
79 OBESITY 333 0.0209
80 WOUND 584 0.0209
81 IRRITABLE BOWEL SYNDROME 441 0.0205
82 LIVER INJURY 500 0.0203
83 PSORIATIC ARTHROPATHY 825 0.0203
84 HYPERCHOLESTEROLAEMIA 194 0.0201
85 HALLUCINATIONS, MIXED 81 0.0192
86 EXOSTOSIS 166 0.0182
87 INFUSION SITE SCAR 8 0.0181
88 WALKING AID USER 117 0.0177
89 ULCER HAEMORRHAGE 119 0.0176
90 PRESCRIBED OVERDOSE 337 0.0174
91 TRACHEAL DISORDER 9 0.0173
92 GRANULOMA SKIN 14 0.0171
93 LUPUS-LIKE SYNDROME 154 0.0170
94 FIXED ERUPTION 29 0.0168
95 JOINT DESTRUCTION 26 0.0167
96 BODY FAT DISORDER 9 0.0166
97 POLYCHONDRITIS 7 0.0166
98 TYPE 2 DIABETES MELLITUS 545 0.0162
99 PULMONARY FIBROSIS 301 0.0157
100 SPONDYLOARTHROPATHY 9 0.0150
101 SYSTEMIC LUPUS ERYTHEMATOSUS 531 0.0149
102 BREAST CANCER STAGE II 124 0.0149
103 AIR EMBOLISM 7 0.0149
104 HIP ARTHROPLASTY 227 0.0148
105 CONTRAINDICATED PRODUCT ADMINISTERED 442 0.0146
106 IMPAIRED HEALING 473 0.0144
107 EYE INJURY 42 0.0138
108 SACROILIITIS 26 0.0138
109 FOOT DEFORMITY 146 0.0132
110 SPONDYLITIS 47 0.0129
111 URINE LEUKOCYTE ESTERASE POSITIVE 9 0.0129
112 RHEUMATOID LUNG 12 0.0126
113 WOUND COMPLICATION 43 0.0125
114 NIGHT SWEATS 398 0.0123
115 PRESCRIBED UNDERDOSE 245 0.0123
116 BLOOD CHOLESTEROL INCREASED 564 0.0121
117 QUADRIPARESIS 19 0.0114
118 ARTHROPATHY 636 0.0114
119 AXIAL SPONDYLOARTHRITIS 10 0.0114
120 JOINT DISLOCATION 119 0.0112
121 OSTEOARTHRITIS 476 0.0112
122 BLEPHAROSPASM 70 0.0111
123 MULTIPLE ALLERGIES 87 0.0111
124 PREGNANCY 222 0.0111
125 ROAD TRAFFIC ACCIDENT 455 0.0109
126 DEVELOPMENTAL HIP DYSPLASIA 9 0.0108
127 LOWER RESPIRATORY TRACT INFECTION 488 0.0107
128 KNEE ARTHROPLASTY 225 0.0107
129 GAIT INABILITY 355 0.0106
130 BASOPHIL COUNT INCREASED 8 0.0106
131 ADENOMA BENIGN 9 0.0105
132 GASTROINTESTINAL NEOPLASM 9 0.0104
133 THERMAL BURN 73 0.0103
134 OEDEMA 557 0.0103
135 LIVER DISORDER 448 0.0101
136 BLISTER 553 0.0098
137 THERAPEUTIC PRODUCT EFFECT DECREASED 435 0.0097
138 AMAUROSIS 8 0.0095
139 BLOOD PARATHYROID HORMONE DECREASED 14 0.0094
140 DISCOMFORT 572 0.0094
141 COLON NEOPLASM 9 0.0093
142 HEPATIC CIRRHOSIS 175 0.0093
143 SPINAL CORD INFECTION 6 0.0092
144 COLITIS MICROSCOPIC 43 0.0091
145 MUSCULOSKELETAL PAIN 472 0.0090
146 DILATED CARDIOMYOPATHY 9 0.0089
147 MOBILITY DECREASED 627 0.0087
148 PEPTIC ULCER HAEMORRHAGE 6 0.0086
149 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 9 0.0085
150 WHEEZING 502 0.0085
151 MYOFASCIAL PAIN SYNDROME 6 0.0084
152 LUNG DISORDER 409 0.0083
153 HEPATIC ENZYME INCREASED 555 0.0081
154 INFUSION SITE REACTION 24 0.0080
155 STOMATITIS 487 0.0080
156 DELIRIUM 278 0.0080
157 SINUSITIS 815 0.0079
158 DRUG TOLERANCE 40 0.0079
159 INFUSION RELATED REACTION 523 0.0079
160 MAST CELL ACTIVATION SYNDROME 11 0.0078
161 TREATMENT FAILURE 647 0.0078
162 INFUSION SITE DISCOMFORT 8 0.0077
163 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 132 0.0077
164 RHEUMATOID ARTHRITIS 868 0.0076
165 ONYCHOMADESIS 32 0.0076
166 HYPERTRANSAMINASAEMIA 53 0.0076
167 THERAPY NON-RESPONDER 342 0.0076
168 DRUG INTOLERANCE 731 0.0076
169 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 123 0.0072
170 RESPIRATORY DISORDER 215 0.0072
171 DUODENAL PERFORATION 7 0.0071
172 INJURY 501 0.0071
173 BRAIN HYPOXIA 7 0.0070
174 EAR PAIN 135 0.0069
175 HYPOCHROMIC ANAEMIA 7 0.0069
176 SPINAL FUSION SURGERY 28 0.0069
177 EYE COLOUR CHANGE 7 0.0069
178 OBSTRUCTIVE SLEEP APNOEA SYNDROME 10 0.0069
179 MUSCULOSKELETAL STIFFNESS 598 0.0068
180 CONVERSION DISORDER 13 0.0067
181 HEPATIC ENZYME ABNORMAL 33 0.0066
182 INFUSION SITE RASH 9 0.0066
183 INFUSION SITE WARMTH 8 0.0065
184 NAIL DISORDER 56 0.0064
185 ILL-DEFINED DISORDER 384 0.0063
186 PRODUCT MONITORING ERROR 9 0.0062
187 TENOSYNOVITIS 17 0.0062
188 METABOLIC SYNDROME 10 0.0061
189 FLANK PAIN 57 0.0061
190 SWELLING 567 0.0061
191 DRY MOUTH 484 0.0060
192 WEIGHT FLUCTUATION 62 0.0059
193 GASTROINTESTINAL DISORDER 529 0.0059
194 EAR INFECTION 156 0.0059
195 JOINT SWELLING 703 0.0058
196 PUSTULAR PSORIASIS 20 0.0058
197 RHEUMATOID NODULE 16 0.0058
198 PANNICULITIS 14 0.0058
199 URINE KETONE BODY PRESENT 9 0.0057
200 ALANINE AMINOTRANSFERASE ABNORMAL 12 0.0057
201 INFLAMMATION 293 0.0057
202 PLANTAR FASCIITIS 19 0.0057
203 C-REACTIVE PROTEIN INCREASED 204 0.0056
204 SLEEP DISORDER 393 0.0056
205 CATARACT OPERATION 33 0.0056
206 MYOCARDIAL NECROSIS MARKER INCREASED 9 0.0054
207 PSYCHOMOTOR SKILLS IMPAIRED 14 0.0053
208 CONTUSION 500 0.0052
209 FREQUENT BOWEL MOVEMENTS 140 0.0052
210 NEPHROGENIC ANAEMIA 24 0.0052
211 LIP ULCERATION 6 0.0051
212 ABSCESS ORAL 7 0.0051
213 GENERAL PHYSICAL HEALTH DETERIORATION 576 0.0050
214 MATERNAL EXPOSURE DURING PREGNANCY 442 0.0050
215 DISABILITY 98 0.0050
216 JOINT STIFFNESS 128 0.0049
217 POLYARTHRITIS 25 0.0047
218 GASTRIC ULCER PERFORATION 6 0.0047
219 ADVERSE REACTION 62 0.0047
220 HALLUCINATION, AUDITORY 74 0.0047
221 REBOUND ACID HYPERSECRETION 14 0.0046
222 ASTHMA 514 0.0045
223 AORTIC VALVE INCOMPETENCE 19 0.0045
224 DRUG-INDUCED LIVER INJURY 140 0.0045
225 LIVER FUNCTION TEST INCREASED 95 0.0044
226 NORMAL NEWBORN 24 0.0044
227 AMNESIA 287 0.0044
228 OSTEOPOROSIS 180 0.0044
229 LABORATORY TEST ABNORMAL 129 0.0044
230 IMMUNODEFICIENCY 65 0.0044
231 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 310 0.0044
232 SEBORRHOEIC DERMATITIS 7 0.0042
233 DUODENAL ULCER 29 0.0041
234 HYPOAESTHESIA 614 0.0041
235 JUVENILE IDIOPATHIC ARTHRITIS 10 0.0041
236 BACTERIAL TEST POSITIVE 9 0.0040
237 HYPERPARATHYROIDISM SECONDARY 10 0.0040
238 VITREOUS HAEMORRHAGE 11 0.0040
239 SECONDARY ADRENOCORTICAL INSUFFICIENCY 6 0.0040
240 HISTOPLASMOSIS 7 0.0040
241 WHITE BLOOD CELL COUNT INCREASED 151 0.0039
242 ORAL PRURITUS 9 0.0039
243 JOINT ARTHROPLASTY 7 0.0039
244 DISCOURAGEMENT 9 0.0038
245 ESCHERICHIA BACTERAEMIA 9 0.0038
246 OSTEOPENIA 57 0.0038
247 GRANULOMA 13 0.0038
248 INFECTION 543 0.0037
249 RASH VESICULAR 18 0.0037
250 ONYCHOMYCOSIS 16 0.0036
251 INTENTIONAL PRODUCT USE ISSUE 319 0.0036
252 CONFUSIONAL STATE 587 0.0036
253 ATROPHY 7 0.0036
254 RECTAL HAEMORRHAGE 154 0.0036
255 ABDOMINAL DISCOMFORT 590 0.0035
256 LAZINESS 6 0.0035
257 AORTIC ARTERIOSCLEROSIS 9 0.0035
258 ARTHRITIS 275 0.0035
259 ANKYLOSING SPONDYLITIS 46 0.0035
260 SKIN REACTION 49 0.0035
261 SKIN NECROSIS 18 0.0035
262 PANCREATITIS 182 0.0034
263 ANGIONEUROTIC OEDEMA 9 0.0034
264 RED CELL DISTRIBUTION WIDTH INCREASED 14 0.0034
265 PERIPHERAL SWELLING 519 0.0034
266 COLITIS ULCERATIVE 150 0.0034
267 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 159 0.0033
268 MEMORY IMPAIRMENT 447 0.0033
269 EOSINOPHIL COUNT INCREASED 27 0.0032
270 ACUTE PSYCHOSIS 8 0.0032
271 MYOSITIS 29 0.0032
272 PRE-EXISTING CONDITION IMPROVED 20 0.0032
273 CEREBELLAR SYNDROME 7 0.0032
274 ALOPECIA 624 0.0032
275 HYPERSENSITIVITY 587 0.0032
276 DYSPNOEA AT REST 9 0.0031
277 HYPERTENSION 657 0.0031
278 FINGER DEFORMITY 15 0.0031
279 EXPOSURE DURING PREGNANCY 192 0.0031
280 BACK INJURY 33 0.0030
281 NASOPHARYNGITIS 559 0.0030
282 CONDITION AGGRAVATED 915 0.0030
283 GASTRITIS EROSIVE 14 0.0030
284 GASTROINTESTINAL MOTILITY DISORDER 16 0.0030
285 ADRENAL INSUFFICIENCY 36 0.0030
286 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 23 0.0030
287 URTICARIA 495 0.0030
288 UVEITIS 40 0.0029
289 ABDOMINAL PAIN UPPER 607 0.0029
290 HERNIA 57 0.0029
291 OSTEOLYSIS 6 0.0029
292 GOITRE 12 0.0029
293 MULTIPLE FRACTURES 48 0.0029
294 PRODUCT LABEL CONFUSION 17 0.0029
295 MUSCULAR WEAKNESS 331 0.0029
296 TRICUSPID VALVE INCOMPETENCE 23 0.0029
297 TASTE DISORDER 58 0.0029
298 INFUSION SITE PRURITUS 9 0.0028
299 DYSPEPSIA 279 0.0028
300 BUNDLE BRANCH BLOCK LEFT 12 0.0028
301 MIGRAINE 268 0.0028
302 DUODENAL ULCER HAEMORRHAGE 8 0.0028
303 OSTEITIS 7 0.0028
304 HAEMATOCRIT DECREASED 55 0.0028
305 CHEST PAIN 508 0.0027
306 DECREASED APPETITE 636 0.0027
307 ADVERSE EVENT 250 0.0027
308 PEPTIC ULCER 9 0.0027
309 ANXIETY DISORDER 9 0.0027
310 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 6 0.0027
311 FEELING HOT 164 0.0027
312 THERAPEUTIC RESPONSE DECREASED 161 0.0027
313 URINE ABNORMALITY 12 0.0026
314 FIBROSIS 8 0.0026
315 WEIGHT INCREASED 582 0.0026
316 MEDICATION ERROR 142 0.0026
317 OEDEMA PERIPHERAL 311 0.0025
318 RASH PRURITIC 137 0.0025
319 MYOPIA 6 0.0025
320 STAPHYLOCOCCAL INFECTION 83 0.0025
321 PRODUCT USE ISSUE 467 0.0025
322 MITRAL VALVE INCOMPETENCE 28 0.0025
323 INGUINAL HERNIA 15 0.0025
324 GLAUCOMA 47 0.0024
325 CARDIAC DYSFUNCTION 9 0.0024
326 CYTOLYTIC HEPATITIS 8 0.0024
327 LUMBAR SPINAL STENOSIS 7 0.0024
328 END STAGE RENAL DISEASE 42 0.0023
329 ULCER 36 0.0023
330 ACCIDENT AT WORK 5 0.0023
331 ADVERSE DRUG REACTION 203 0.0023
332 BLEPHARITIS 9 0.0022
333 FEAR OF INJECTION 16 0.0022
334 CHOLECYSTITIS CHRONIC 15 0.0022
335 MENINGITIS ASEPTIC 10 0.0022
336 ARTHRALGIA 917 0.0022
337 TENDONITIS 34 0.0022
338 HYPERURICAEMIA 9 0.0022
339 CHRONIC KIDNEY DISEASE 166 0.0022
340 ANXIETY 619 0.0022
341 BLOOD PRESSURE DIASTOLIC INCREASED 10 0.0022
342 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 7 0.0022
343 EUPHORIC MOOD 22 0.0021
344 COELIAC DISEASE 21 0.0021
345 RASH 930 0.0021
346 DEPRESSION 485 0.0021
347 DIVERTICULITIS 59 0.0021
348 SCOLIOSIS 13 0.0021
349 PARAESTHESIA 329 0.0021
350 LEFT VENTRICULAR DYSFUNCTION 14 0.0021
351 SOCIAL AVOIDANT BEHAVIOUR 12 0.0021
352 EPILEPSY 63 0.0021
353 SPINAL OSTEOARTHRITIS 18 0.0020
354 EPIGASTRIC DISCOMFORT 8 0.0020
355 INFLAMMATORY MARKER INCREASED 10 0.0020
356 TREATMENT NONCOMPLIANCE 110 0.0020
357 DRUG LEVEL BELOW THERAPEUTIC 11 0.0020
358 STEVENS-JOHNSON SYNDROME 44 0.0020
359 IRITIS 6 0.0020
360 DRUG LEVEL ABOVE THERAPEUTIC 9 0.0020
361 ACIDOSIS 15 0.0020
362 HALLUCINATION, VISUAL 41 0.0019
363 BONE LESION 7 0.0019
364 POST-TRAUMATIC STRESS DISORDER 13 0.0019
365 MULTIPLE-DRUG RESISTANCE 6 0.0019
366 TONGUE DISORDER 14 0.0019
367 MUSCLE SPASMS 351 0.0019
368 PRODUCT ADMINISTRATION INTERRUPTED 15 0.0019
369 LEFT VENTRICULAR HYPERTROPHY 8 0.0019
370 BRONCHITIS 137 0.0018
371 GAMMA-GLUTAMYLTRANSFERASE INCREASED 41 0.0018
372 HAEMORRHOIDAL HAEMORRHAGE 9 0.0018
373 GASTRIC ULCER 35 0.0018
374 TONGUE OEDEMA 7 0.0018
375 PULMONARY CONGESTION 24 0.0018
376 GAIT DISTURBANCE 345 0.0018
377 GASTROOESOPHAGEAL REFLUX DISEASE 145 0.0018
378 INSOMNIA 477 0.0018
379 WOUND DEHISCENCE 6 0.0018
380 HEPATIC FIBROSIS 6 0.0017
381 ASPIRATION 19 0.0017
382 GENERAL SYMPTOM 13 0.0017
383 TRIGGER FINGER 7 0.0017
384 SPINAL PAIN 20 0.0017
385 VAGINAL INFECTION 8 0.0017
386 CONGENITAL ANOMALY 13 0.0017
387 PRURITUS 633 0.0016
388 ALANINE AMINOTRANSFERASE INCREASED 101 0.0016
389 UPPER RESPIRATORY TRACT INFECTION 76 0.0016
390 VENTRICULAR ARRHYTHMIA 6 0.0016
391 INFLAMMATORY BOWEL DISEASE 16 0.0016
392 MUSCLE SPASTICITY 20 0.0016
393 OLIGURIA 10 0.0016
394 BLOOD ALKALINE PHOSPHATASE INCREASED 40 0.0016
395 NEPHROPATHY 15 0.0016
396 BACK DISORDER 26 0.0016
397 ANAPHYLACTIC REACTION 88 0.0016
398 LIGAMENT RUPTURE 7 0.0016
399 PHOTOPSIA 10 0.0016
400 NECK PAIN 88 0.0016
401 ASTHENIA 592 0.0016
402 BODY TEMPERATURE INCREASED 32 0.0016
403 MOUTH SWELLING 9 0.0016
404 HAND FRACTURE 11 0.0016
405 PANIC DISORDER 6 0.0015
406 POOR VENOUS ACCESS 16 0.0015
407 DRUG ERUPTION 27 0.0015
408 PHARYNGOLARYNGEAL PAIN 8 0.0015
409 HYPERPHAGIA 6 0.0015
410 PYREXIA 520 0.0015
411 ABDOMINAL PAIN 349 0.0015
412 WEIGHT DECREASED 416 0.0015
413 CYSTITIS 47 0.0015
414 JOINT INJURY 31 0.0014
415 VENTRICULAR EXTRASYSTOLES 15 0.0014
416 BLOOD CREATININE INCREASED 94 0.0014
417 CONGESTIVE CARDIOMYOPATHY 6 0.0014
418 ERECTION INCREASED 6 0.0014
419 ATAXIA 17 0.0014
420 MALAISE 627 0.0014
421 EYE DISORDER 47 0.0014
422 DIPLOPIA 37 0.0014
423 INTERVERTEBRAL DISC PROTRUSION 31 0.0014
424 LIGAMENT SPRAIN 14 0.0014
425 VISUAL IMPAIRMENT 175 0.0014
426 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
427 DIVERTICULUM 10 0.0014
428 VOMITING 660 0.0014
429 GOUT 25 0.0014
430 PAIN IN EXTREMITY 409 0.0014
431 BLOOD PRESSURE SYSTOLIC INCREASED 27 0.0014
432 OSTEOMYELITIS 25 0.0014
433 LEUKOPENIA 69 0.0014
434 PAIN 847 0.0014
435 ORAL CANDIDIASIS 18 0.0014
436 HAEMORRHAGIC ANAEMIA 6 0.0014
437 RHINITIS 11 0.0014
438 SLEEP APNOEA SYNDROME 26 0.0014
439 TOOTH FRACTURE 15 0.0014
440 GINGIVAL SWELLING 6 0.0014
441 ANGIOEDEMA 60 0.0014
442 RHINITIS ALLERGIC 6 0.0013
443 BASAL CELL CARCINOMA 21 0.0013
444 MOUTH ULCERATION 28 0.0013
445 HEPATITIS CHOLESTATIC 8 0.0013
446 CATARACT 79 0.0013
447 DRUG EFFECT INCOMPLETE 48 0.0013
448 RENAL PAIN 14 0.0013
449 DIARRHOEA 852 0.0013
450 TOXIC EPIDERMAL NECROLYSIS 20 0.0013
451 IMMUNE THROMBOCYTOPENIA 6 0.0013
452 MYOCARDITIS 15 0.0013
453 CARDIOMEGALY 16 0.0013
454 SYNOVIAL CYST 6 0.0013
455 STRESS FRACTURE 7 0.0013
456 HYPERCALCAEMIA 16 0.0013
457 ARTHRITIS INFECTIVE 6 0.0013
458 CONCUSSION 10 0.0013
459 BLOOD PRESSURE FLUCTUATION 31 0.0013
460 HERPES ZOSTER 74 0.0013
461 ERYTHEMA MULTIFORME 12 0.0013
462 UMBILICAL HERNIA 6 0.0013
463 TUBULOINTERSTITIAL NEPHRITIS 24 0.0013
464 PHOTOSENSITIVITY REACTION 21 0.0013
465 INFUSION SITE SWELLING 8 0.0013
466 SPINAL COLUMN STENOSIS 6 0.0013
467 UNDERDOSE 92 0.0013
468 RENAL CYST 10 0.0013
469 HYPERLIPIDAEMIA 15 0.0013
470 PANCYTOPENIA 70 0.0013
471 TENDERNESS 13 0.0012
472 PANIC REACTION 9 0.0012
473 DERMATITIS BULLOUS 9 0.0012
474 PRODUCT USE IN UNAPPROVED INDICATION 308 0.0012
475 DERMATITIS CONTACT 14 0.0012
476 RESPIRATORY DEPRESSION 15 0.0012
477 SOMNAMBULISM 8 0.0012
478 HAEMATOCHEZIA 67 0.0012
479 FOOT OPERATION 6 0.0012
480 DIABETIC NEUROPATHY 6 0.0012
481 DRUG RESISTANCE 31 0.0012
482 HEADACHE 755 0.0012
483 VEIN DISORDER 6 0.0012
484 BLOOD THYROID STIMULATING HORMONE INCREASED 11 0.0012
485 DIZZINESS 595 0.0012
486 QUALITY OF LIFE DECREASED 16 0.0012
487 DRUG USE DISORDER 10 0.0012
488 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
489 UPPER GASTROINTESTINAL HAEMORRHAGE 20 0.0012
490 COLITIS ISCHAEMIC 8 0.0012
491 THINKING ABNORMAL 22 0.0012
492 RENAL DISORDER 55 0.0012
493 BLOOD IRON DECREASED 14 0.0012
494 TOOTH ABSCESS 12 0.0012
495 DYSPNOEA 659 0.0012
496 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
497 JOINT EFFUSION 8 0.0012
498 PSYCHOLOGICAL TRAUMA 10 0.0012
499 BURNING SENSATION 81 0.0012
500 SCHIZOPHRENIA 14 0.0012
501 MYELOSUPPRESSION 41 0.0011
502 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 10 0.0011
503 VITAMIN D DEFICIENCY 11 0.0011
504 HYPOKALAEMIA 52 0.0011
505 SENSORY DISTURBANCE 18 0.0011
506 RENAL IMPAIRMENT 94 0.0011
507 THROMBOCYTOPENIA 125 0.0011
508 FATIGUE 863 0.0011
509 POST PROCEDURAL INFECTION 9 0.0011
510 GASTRITIS 29 0.0011
511 BLOOD PRESSURE DIASTOLIC DECREASED 8 0.0011
512 MOTOR DYSFUNCTION 11 0.0011
513 ANGINA UNSTABLE 7 0.0011
514 RESPIRATORY TRACT INFECTION 28 0.0011
515 HAEMATEMESIS 27 0.0011
516 NAUSEA 837 0.0011
517 CIRCULATORY COLLAPSE 18 0.0011
518 APPETITE DISORDER 7 0.0011
519 POISONING DELIBERATE 10 0.0011
520 MUSCULOSKELETAL DISORDER 20 0.0010
521 CARDIAC VALVE DISEASE 6 0.0010
522 PNEUMONIA 338 0.0010
523 RENAL INJURY 31 0.0010
524 MYOPATHY 9 0.0010
525 HYPONATRAEMIA 58 0.0010
526 ANHEDONIA 27 0.0010
527 GINGIVAL BLEEDING 14 0.0010
528 MATERNAL EXPOSURE BEFORE PREGNANCY 7 0.0010
529 LIP SWELLING 34 0.0010
530 HEPATOMEGALY 10 0.0010
531 RENAL FAILURE 135 0.0010
532 PLEURISY 6 0.0010
533 FACE OEDEMA 17 0.0010
534 MELAENA 22 0.0010
535 OPTIC NEURITIS 9 0.0010
536 TENSION 6 0.0010
537 NEUTROPHIL COUNT INCREASED 10 0.0010
538 SKIN ULCER 25 0.0010
539 MYOCARDIAL ISCHAEMIA 11 0.0010
540 HEPATIC STEATOSIS 18 0.0010
541 GASTROENTERITIS 14 0.0010
542 ARTERIOSCLEROSIS 9 0.0010
543 GASTRIC HAEMORRHAGE 11 0.0010
544 BRAIN OEDEMA 12 0.0009
545 EYELID OEDEMA 11 0.0009
546 TACHYCARDIA 84 0.0009
547 SCREAMING 6 0.0009
548 INADEQUATE ANALGESIA 8 0.0009
549 BONE DISORDER 17 0.0009
550 ECONOMIC PROBLEM 14 0.0009
551 HAEMODYNAMIC INSTABILITY 7 0.0009
552 RENAL TUBULAR NECROSIS 9 0.0009
553 SEDATION 24 0.0009
554 BODY TEMPERATURE DECREASED 9 0.0009
555 MANIA 15 0.0009
556 NEURALGIA 22 0.0009
557 APHTHOUS ULCER 7 0.0009
558 HYPOCALCAEMIA 17 0.0009
559 FOOT FRACTURE 17 0.0009
560 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 23 0.0009
561 GASTROINTESTINAL INFLAMMATION 7 0.0009
562 APATHY 13 0.0009
563 TENDON RUPTURE 11 0.0009
564 OFF LABEL USE 780 0.0009
565 AFFECTIVE DISORDER 7 0.0009
566 PHARYNGITIS 11 0.0009
567 CYST 11 0.0009
568 DRUG TOXICITY 12 0.0009
569 DRUG INTERACTION 139 0.0009
570 CHOLECYSTECTOMY 10 0.0009
571 BACK PAIN 203 0.0009
572 OBSESSIVE-COMPULSIVE DISORDER 7 0.0009
573 MUSCULOSKELETAL DISCOMFORT 15 0.0009
574 RESPIRATORY ARREST 24 0.0009
575 GASTROINTESTINAL HAEMORRHAGE 72 0.0009
576 SHOCK HAEMORRHAGIC 7 0.0009
577 CORONARY ARTERY DISEASE 26 0.0009
578 VASCULITIS 10 0.0009
579 HAEMOGLOBIN DECREASED 88 0.0009
580 MIDDLE INSOMNIA 16 0.0009
581 INCONTINENCE 9 0.0009
582 PANIC ATTACK 31 0.0008
583 HIATUS HERNIA 11 0.0008
584 HAEMATOMA 22 0.0008
585 INTESTINAL OBSTRUCTION 32 0.0008
586 RASH PAPULAR 19 0.0008
587 DIABETES MELLITUS INADEQUATE CONTROL 15 0.0008
588 ASPARTATE AMINOTRANSFERASE INCREASED 45 0.0008
589 PHARYNGEAL OEDEMA 13 0.0008
590 RETINAL HAEMORRHAGE 6 0.0008
591 HEMIPLEGIA 7 0.0008
592 BRONCHOSPASM 12 0.0008
593 PRODUCT PRESCRIBING ERROR 20 0.0008
594 POLYNEUROPATHY 10 0.0008
595 PRURITUS GENERALISED 18 0.0008
596 GASTROENTERITIS VIRAL 15 0.0008
597 HYPERTHYROIDISM 12 0.0008
598 TOOTHACHE 15 0.0008
599 ATELECTASIS 8 0.0008
600 BIPOLAR DISORDER 9 0.0008
601 HAEMORRHOIDS 16 0.0008
602 GASTROINTESTINAL PAIN 9 0.0008
603 BLOOD PRESSURE INCREASED 125 0.0008
604 CELLULITIS 41 0.0008
605 RASH MACULO-PAPULAR 18 0.0008
606 AGRANULOCYTOSIS 15 0.0008
607 NEPHROLITHIASIS 37 0.0008
608 ACUTE HEPATIC FAILURE 11 0.0008
609 INTESTINAL PERFORATION 9 0.0008
610 HYDRONEPHROSIS 6 0.0008
611 IMMUNOSUPPRESSION 7 0.0008
612 LYMPHOCYTE COUNT DECREASED 14 0.0008
613 ACUTE KIDNEY INJURY 121 0.0008
614 RESPIRATORY RATE INCREASED 7 0.0008
615 CARDIOVASCULAR DISORDER 20 0.0008
616 DYSSTASIA 23 0.0008
617 HYPERTHERMIA 6 0.0008
618 CARPAL TUNNEL SYNDROME 11 0.0008
619 HYPOTHYROIDISM 25 0.0008
620 PULMONARY OEDEMA 35 0.0008
621 RENAL FAILURE CHRONIC 6 0.0008
622 INFUSION SITE PAIN 10 0.0008
623 ANOREXIA 10 0.0008
624 HAEMORRHAGIC STROKE 6 0.0008
625 PLATELET COUNT INCREASED 10 0.0008
626 PARAESTHESIA ORAL 11 0.0008
627 PSORIASIS 99 0.0008
628 FURUNCLE 6 0.0008
629 PANCREATITIS ACUTE 17 0.0008
630 CONJUNCTIVITIS 14 0.0008
631 ASCITES 22 0.0007
632 HEPATITIS 19 0.0007
633 DISTURBANCE IN ATTENTION 40 0.0007
634 TOXICITY TO VARIOUS AGENTS 125 0.0007
635 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
636 SMALL INTESTINAL OBSTRUCTION 9 0.0007
637 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
638 ESCHERICHIA INFECTION 6 0.0007
639 POISONING 9 0.0007
640 DERMATITIS ALLERGIC 9 0.0007
641 HYPERKALAEMIA 25 0.0007
642 SKIN PLAQUE 6 0.0007
643 ACCIDENTAL OVERDOSE 26 0.0007
644 WHITE BLOOD CELL COUNT DECREASED 77 0.0007
645 DEEP VEIN THROMBOSIS 46 0.0007
646 RENAL FAILURE ACUTE 30 0.0007
647 PAIN IN JAW 20 0.0007
648 HEPATIC CYTOLYSIS 9 0.0007
649 SWOLLEN TONGUE 22 0.0007
650 LOCALISED INFECTION 17 0.0007
651 BONE DENSITY DECREASED 22 0.0007
652 GASTRIC DISORDER 24 0.0007
653 EMPHYSEMA 7 0.0007
654 HYSTERECTOMY 6 0.0007
655 ABSCESS 11 0.0007
656 GROIN PAIN 6 0.0007
657 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
658 CHOLESTASIS 13 0.0007
659 EYE HAEMORRHAGE 9 0.0007
660 COMA 32 0.0007
661 MYOCLONUS 8 0.0007
662 ORAL PAIN 15 0.0007
663 FEAR 18 0.0007
664 SUICIDAL IDEATION 61 0.0007
665 ORAL HERPES 13 0.0007
666 HEART RATE IRREGULAR 15 0.0007
667 DRUG INEFFECTIVE 871 0.0007
668 RESTLESS LEGS SYNDROME 12 0.0007
669 SYNCOPE 66 0.0007
670 BLOOD UREA INCREASED 11 0.0007
671 DEVICE FAILURE 10 0.0007
672 BODY HEIGHT DECREASED 7 0.0007
673 MOVEMENT DISORDER 21 0.0007
674 LIVER FUNCTION TEST ABNORMAL 19 0.0007
675 RETINAL DETACHMENT 6 0.0007
676 DECREASED ACTIVITY 7 0.0006
677 BREAST CANCER STAGE I 6 0.0006
678 OESOPHAGITIS 7 0.0006
679 PLATELET COUNT DECREASED 68 0.0006
680 DYSARTHRIA 24 0.0006
681 DYSPNOEA EXERTIONAL 24 0.0006
682 SPINAL DISORDER 6 0.0006
683 BLOOD URINE PRESENT 12 0.0006
684 MUSCLE ATROPHY 8 0.0006
685 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
686 DISORIENTATION 25 0.0006
687 RESPIRATORY TRACT CONGESTION 10 0.0006
688 MULTIPLE SCLEROSIS 30 0.0006
689 HYPOPHAGIA 16 0.0006
690 LOSS OF CONSCIOUSNESS 80 0.0006
691 RHABDOMYOLYSIS 26 0.0006
692 COGNITIVE DISORDER 29 0.0006
693 CHROMATURIA 14 0.0006
694 MICTURITION URGENCY 7 0.0006
695 MUCOSAL INFLAMMATION 16 0.0006
696 FEELING COLD 17 0.0006
697 FLUID RETENTION 31 0.0006
698 IMMUNE SYSTEM DISORDER 8 0.0006
699 DIABETES MELLITUS 46 0.0006
700 EYE PAIN 34 0.0006
701 RESTLESSNESS 22 0.0006
702 SOMNOLENCE 121 0.0006
703 COMPLETED SUICIDE 50 0.0006
704 URINARY RETENTION 20 0.0006
705 BONE LOSS 9 0.0006
706 LYMPHADENOPATHY 21 0.0006
707 HIP FRACTURE 19 0.0006
708 EYELID PTOSIS 6 0.0006
709 BLOOD PRESSURE DECREASED 39 0.0006
710 IMPAIRED GASTRIC EMPTYING 8 0.0006
711 SCAR 10 0.0006
712 RIB FRACTURE 12 0.0006
713 INTENTIONAL PRODUCT MISUSE 51 0.0006
714 ANKLE FRACTURE 9 0.0006
715 URINARY TRACT INFECTION 99 0.0006
716 TOOTH LOSS 12 0.0006
717 PROTEINURIA 11 0.0006
718 NOCTURIA 7 0.0006
719 MENTAL STATUS CHANGES 16 0.0006
720 NERVOUSNESS 30 0.0006
721 NO THERAPEUTIC RESPONSE 7 0.0006
722 DEAFNESS 15 0.0006
723 GENERALISED OEDEMA 7 0.0006
724 SEASONAL ALLERGY 8 0.0006
725 TOOTH EXTRACTION 7 0.0006
726 LEUKOCYTOSIS 10 0.0006
727 HOSPITALISATION 84 0.0005
728 ROTATOR CUFF SYNDROME 7 0.0005
729 VENTRICULAR TACHYCARDIA 9 0.0005
730 SUICIDE ATTEMPT 33 0.0005
731 DENTAL CARIES 6 0.0005
732 CARDIOMYOPATHY 8 0.0005
733 HEART RATE DECREASED 19 0.0005
734 COAGULOPATHY 9 0.0005
735 OROPHARYNGEAL PAIN 50 0.0005
736 URINARY INCONTINENCE 16 0.0005
737 MYOCARDIAL INFARCTION 94 0.0005
738 EYE SWELLING 20 0.0005
739 HYPOGLYCAEMIA 26 0.0005
740 BLOOD GLUCOSE INCREASED 101 0.0005
741 SKIN INFECTION 6 0.0005
742 BLOOD SODIUM DECREASED 10 0.0005
743 PULMONARY HYPERTENSION 11 0.0005
744 ERYTHEMA 108 0.0005
745 INTERNAL HAEMORRHAGE 6 0.0005
746 AGGRESSION 26 0.0005
747 ORTHOSTATIC HYPOTENSION 9 0.0005
748 DELUSION 8 0.0005
749 IMPAIRED WORK ABILITY 11 0.0005
750 ABDOMINAL PAIN LOWER 13 0.0005
751 THERAPEUTIC RESPONSE UNEXPECTED 23 0.0005
752 SPLENOMEGALY 6 0.0005
753 EMOTIONAL DISTRESS 62 0.0005
754 ACUTE MYOCARDIAL INFARCTION 15 0.0005
755 DISEASE PROGRESSION 60 0.0005
756 SINUS DISORDER 10 0.0005
757 ANAPHYLACTIC SHOCK 13 0.0005
758 AGITATION 37 0.0005
759 ANGER 17 0.0005
760 MYALGIA 85 0.0005
761 SPINAL FRACTURE 10 0.0005
762 BLOOD TEST ABNORMAL 7 0.0005
763 MENTAL IMPAIRMENT 12 0.0005
764 LYMPHOPENIA 7 0.0005
765 TRANSAMINASES INCREASED 11 0.0005
766 ANGINA PECTORIS 14 0.0005
767 IMPAIRED QUALITY OF LIFE 7 0.0005
768 PALPITATIONS 57 0.0005
769 ATRIAL FIBRILLATION 47 0.0005
770 VISUAL ACUITY REDUCED 16 0.0005
771 SKIN DISCOLOURATION 22 0.0005
772 PLEURAL EFFUSION 29 0.0005
773 PSYCHOTIC DISORDER 14 0.0005
774 FALL 156 0.0005
775 POST PROCEDURAL COMPLICATION 9 0.0005
776 CRYING 17 0.0005
777 INJECTION SITE INDURATION 6 0.0005
778 UNEVALUABLE EVENT 35 0.0005
779 FAECES DISCOLOURED 10 0.0005
780 SWELLING FACE 30 0.0005
781 RASH ERYTHEMATOUS 22 0.0005
782 HYPOTENSION 92 0.0005
783 EOSINOPHILIA 8 0.0005
784 TOOTH INFECTION 6 0.0005
785 RED BLOOD CELL COUNT DECREASED 13 0.0005
786 COLD SWEAT 8 0.0005
787 LYMPHOMA 7 0.0005
788 MUSCULOSKELETAL CHEST PAIN 7 0.0005
789 TOOTH DISORDER 10 0.0004
790 HEPATOTOXICITY 10 0.0004
791 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 91 0.0004
792 CARDIAC ARREST 37 0.0004
793 JAUNDICE 12 0.0004
794 ABASIA 11 0.0004
795 SINUS CONGESTION 6 0.0004
796 PALLOR 12 0.0004
797 PNEUMONIA ASPIRATION 11 0.0004
798 HYPERGLYCAEMIA 16 0.0004
799 HALLUCINATION 33 0.0004
800 SKIN LESION 12 0.0004
801 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
802 TINNITUS 20 0.0004
803 LACTIC ACIDOSIS 14 0.0004
804 HUNGER 6 0.0004
805 DERMATITIS 9 0.0004
806 PRODUCT QUALITY ISSUE 58 0.0004
807 CHOLELITHIASIS 14 0.0004
808 RASH GENERALISED 11 0.0004
809 HEART RATE INCREASED 42 0.0004
810 PHARMACEUTICAL PRODUCT COMPLAINT 11 0.0004
811 THROAT IRRITATION 19 0.0004
812 SKIN DISORDER 14 0.0004
813 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 23 0.0004
814 CONSTIPATION 91 0.0004
815 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
816 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
817 EPISTAXIS 31 0.0004
818 MENTAL DISORDER 18 0.0004
819 ABDOMINAL DISTENSION 43 0.0004
820 DYSPHAGIA 39 0.0004
821 COUGH 115 0.0004
822 BONE PAIN 24 0.0004
823 POLLAKIURIA 17 0.0004
824 INJECTION SITE URTICARIA 10 0.0004
825 MENORRHAGIA 8 0.0004
826 PARANOIA 7 0.0004
827 MULTI-ORGAN FAILURE 7 0.0004
828 MOOD ALTERED 11 0.0004
829 PULMONARY MASS 6 0.0004
830 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 21 0.0004
831 RHINORRHOEA 26 0.0004
832 PULMONARY EMBOLISM 38 0.0004
833 HYPOAESTHESIA ORAL 6 0.0004
834 TREMOR 66 0.0004
835 OSTEONECROSIS 13 0.0004
836 COLITIS 15 0.0004
837 FEEDING DISORDER 8 0.0004
838 GALLBLADDER DISORDER 7 0.0004
839 PERICARDIAL EFFUSION 9 0.0004
840 INJECTION SITE WARMTH 8 0.0004
841 FLATULENCE 22 0.0004
842 PERITONITIS 8 0.0004
843 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
844 ANAEMIA 73 0.0004
845 VISION BLURRED 52 0.0004
846 ABNORMAL BEHAVIOUR 15 0.0004
847 RASH MACULAR 13 0.0004
848 DRUG EFFECT DECREASED 20 0.0004
849 DYSKINESIA 15 0.0004
850 INFLUENZA 41 0.0004
851 DEHYDRATION 49 0.0004
852 INCREASED APPETITE 7 0.0004
853 HYPERHIDROSIS 47 0.0004
854 LACRIMATION INCREASED 11 0.0004
855 DRUG LEVEL INCREASED 6 0.0004
856 THERAPEUTIC RESPONSE SHORTENED 12 0.0004
857 CHOKING 7 0.0004
858 INJECTION SITE PRURITUS 24 0.0004
859 SURGERY 21 0.0004
860 NEUROPATHY PERIPHERAL 34 0.0004
861 SNEEZING 8 0.0004
862 HEMIPARESIS 6 0.0004
863 DYSURIA 13 0.0004
864 FEELING ABNORMAL 84 0.0004
865 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 63 0.0003
866 HYPERSOMNIA 10 0.0003
867 SHOCK 8 0.0003
868 MUSCLE TWITCHING 8 0.0003
869 INTENTIONAL SELF-INJURY 7 0.0003
870 SEPTIC SHOCK 15 0.0003
871 LOCAL SWELLING 6 0.0003
872 METASTASES TO LIVER 6 0.0003
873 DEPRESSED MOOD 18 0.0003
874 NASAL CONGESTION 20 0.0003
875 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
876 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
877 ARRHYTHMIA 16 0.0003
878 CARDIAC FAILURE CONGESTIVE 27 0.0003
879 THIRST 6 0.0003
880 FLUSHING 34 0.0003
881 LIMB INJURY 9 0.0003
882 CEREBROVASCULAR ACCIDENT 56 0.0003
883 PRESYNCOPE 8 0.0003
884 RETCHING 7 0.0003
885 ENCEPHALOPATHY 8 0.0003
886 ECZEMA 17 0.0003
887 BALANCE DISORDER 28 0.0003
888 LIMB DISCOMFORT 10 0.0003
889 DYSGEUSIA 24 0.0003
890 BRADYCARDIA 17 0.0003
891 NERVOUS SYSTEM DISORDER 10 0.0003
892 HEAD INJURY 10 0.0003
893 CHILLS 37 0.0003
894 MOOD SWINGS 10 0.0003
895 CHEST DISCOMFORT 32 0.0003
896 INTENTIONAL OVERDOSE 20 0.0003
897 CARDIO-RESPIRATORY ARREST 13 0.0003
898 DYSTONIA 6 0.0003
899 COVID-19 54 0.0003
900 PRODUCT AVAILABILITY ISSUE 7 0.0003
901 KIDNEY INFECTION 6 0.0003
902 RESPIRATORY FAILURE 22 0.0003
903 BLOOD POTASSIUM DECREASED 9 0.0003
904 INJECTION SITE ERYTHEMA 37 0.0003
905 FULL BLOOD COUNT DECREASED 6 0.0003
906 LETHARGY 17 0.0003
907 VERTIGO 18 0.0003
908 DISEASE RECURRENCE 14 0.0003
909 PRODUCTIVE COUGH 14 0.0003
910 ABNORMAL DREAMS 8 0.0003
911 CARDIAC DISORDER 27 0.0003
912 DRUG ABUSE 24 0.0003
913 HAEMORRHAGE 30 0.0003
914 CARDIAC FAILURE 23 0.0003
915 OXYGEN SATURATION DECREASED 16 0.0003
916 HYPOXIA 10 0.0003
917 OSTEONECROSIS OF JAW 7 0.0003
918 IRRITABILITY 17 0.0003
919 DRY EYE 14 0.0003
920 POOR QUALITY SLEEP 6 0.0003
921 INJECTION SITE SWELLING 21 0.0003
922 DRUG WITHDRAWAL SYNDROME 24 0.0003
923 THROMBOSIS 22 0.0003
924 FOETAL EXPOSURE DURING PREGNANCY 22 0.0003
925 VIRAL INFECTION 9 0.0003
926 FUNGAL INFECTION 9 0.0003
927 ILLNESS 27 0.0003
928 EMOTIONAL DISORDER 8 0.0003
929 BLOOD BILIRUBIN INCREASED 7 0.0003
930 THROAT TIGHTNESS 7 0.0003
931 FEMUR FRACTURE 8 0.0003
932 PNEUMONITIS 7 0.0003
933 DYSPHONIA 15 0.0003
934 PROCEDURAL PAIN 7 0.0003
935 METABOLIC ACIDOSIS 8 0.0002
936 DRUG DEPENDENCE 40 0.0002
937 SPEECH DISORDER 13 0.0002
938 WRONG TECHNIQUE IN DRUG USAGE PROCESS 9 0.0002
939 INJECTION SITE REACTION 17 0.0002
940 INJECTION SITE MASS 9 0.0002
941 HEPATIC FUNCTION ABNORMAL 9 0.0002
942 OVERDOSE 52 0.0002
943 HAEMATURIA 8 0.0002
944 INTERSTITIAL LUNG DISEASE 11 0.0002
945 SEIZURE 26 0.0002
946 THERAPY INTERRUPTED 16 0.0002
947 CEREBRAL HAEMORRHAGE 8 0.0002
948 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
949 MULTIPLE SCLEROSIS RELAPSE 15 0.0002
950 TARDIVE DYSKINESIA 6 0.0002
951 HOT FLUSH 16 0.0002
952 FEBRILE NEUTROPENIA 14 0.0002
953 ACNE 16 0.0002
954 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 15 0.0002
955 BLOOD GLUCOSE DECREASED 10 0.0002
956 VAGINAL HAEMORRHAGE 9 0.0002
957 NIGHTMARE 7 0.0002
958 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
959 APHASIA 6 0.0002
960 BLINDNESS 8 0.0002
961 CONVULSION 11 0.0002
962 WITHDRAWAL SYNDROME 8 0.0002
963 DERMATITIS ATOPIC 10 0.0002
964 OCULAR HYPERAEMIA 9 0.0002
965 SEPSIS 21 0.0002
966 INJECTION SITE BRUISING 15 0.0002
967 INFLUENZA LIKE ILLNESS 15 0.0002
968 INJECTION SITE PAIN 55 0.0002
969 PRODUCT DOSE OMISSION ISSUE 52 0.0002
970 INJECTION SITE HAEMORRHAGE 14 0.0002
971 INCORRECT DOSE ADMINISTERED 38 0.0002
972 PRODUCT SUBSTITUTION ISSUE 9 0.0002
973 SKIN BURNING SENSATION 11 0.0002
974 PRODUCT DOSE OMISSION 10 0.0002
975 NEUTROPENIA 20 0.0001
976 LUNG NEOPLASM MALIGNANT 6 0.0001
977 DEVICE ISSUE 13 0.0001
978 DRY SKIN 19 0.0001
979 HYPOACUSIS 6 0.0001
980 DRUG DOSE OMISSION 23 0.0001
981 DEATH 117 0.0001
982 DEVICE MALFUNCTION 9 0.0001
983 THERAPY CESSATION 6 0.0001
984 SKIN EXFOLIATION 9 0.0001
985 NO ADVERSE EVENT 18 0.0001
986 BREAST CANCER 9 0.0001
987 NEOPLASM MALIGNANT 6 0.0001
988 DRUG DOSE OMISSION BY DEVICE 7 0.0001
989 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
990 PRODUCT STORAGE ERROR 7 0.0001
991 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
992 PROSTATE CANCER 6 0.0001